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Abstract
Atherosclerosis is a specific type of arterioscle-
rosis, in which artery walls thickens as a re-
sult of accumulation of cholesterol, toxins,
triglyceride and other irritants and is a re-
sult of processes taking place in a complex
network of cells. Main focus of this pa-
per is on Weighted Gene Co-expression Net-
work Analysis(WGCNA), Feature Selection,
Survival Analysis and Logistic Regression.
WGCNA is a widely-used technique for getting
a better idea of underlying correlation among
the genes. Modules that are obtained as a re-
sult from these network analysis can be used to
find transcription factors or enriched gene on-
tologies . In order to find possible candidate
genes, Survival analysis and Logistic regression
methods are exploited. One problem faced by
both methods is the overfitting problem. Fea-
ture selection and Network-Cox model are used
for dealing with the high dimensionality of the
input. Above mentioned methods, excluding
Network-Cox model, were able to produce set of
genes already associated with the atherosclero-
sis or its symptoms and also introduced possible
new targets, making them an interesting alter-
native to include in future research. Although,
Network-Cox models failed to converge to op-
timal results, they still remain as an engaging
method for the analysis of different data set,
or even the same data set, but for that, some
issues must be solved first.
Keywords: Weighted Gene Correlation Net-
work Analysis, Regression, mRNA, Atheroscle-
rosis, Feature Selection, Networks
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1 Introduction
Atherosclerosis is a heart disease in which an artery wall
thickens as a result of accumulation of calcium and fatty
materials such as cholesterol and triglyceride. When ir-
ritants enter the blood, they may cause the endothelial
cell dysfunction. This dysfunction leads to cholesterol,
toxins and some other irritants to enter the inner layer of
the blood vessels. Sudden reaction of the macrophages
and smooth muscle cells, try to cover the damage and
reduce the amount of irritants, but as a result, they be-
come the part of the inner layer wall of the blood ves-
sel, so leading to the artery walls thickening and losing
flexibility. Figure 1.1, depicts the overall picture of the
atherosclerosis.
Figure 1.1: Overall picture of the atherosclerosis and its
progression
Recent research concerning atherosclerosis focused on
finding new target genes that will lead to better un-
derstanding of the disease and generation of new treat-
ments. Although, most of the research done so far fo-
cused on systems biology methods [1], standard map-
ping techniques, random forests, neural networks and
some others, lately, also some papers have been pub-
lished trying to analyse patient data using more com-
plex and statistical methods. Considering successful us-
age of Weighted Gene Co-expression Network Analysis,
Cox regression models in identification of target genes
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in cancer research[10, 9, 7] lead to the idea of perform-
ing experiments and analysis using these techniques in
research of cardiovascular diseases. The goal and main
focus of this article is to investigate the application of
Weighted Gene Co-expression networks and Cox models
in research of cardiovascular diseases.
Weighted Gene Co-expression networks are proven to
be a powerful tool in analysis of biological networks [10].
Even though, there exists a framework with implementa-
tion of Weighted Gene Co-expression networks [3], there
are still questions to be answered in order to make best
use of the framework. Couple of different analysis tools
and techniques are introduced in order to make better
sense of the results that Weighted Gene Co-expression
(WGCNA) framework returns.
One of the problems introduced by the application
of Cox models is the overfitting problem and their poor
performance on high dimensional data sets. Therefore,
one aspect that will be explored is the possible reduction
of dimensionality of gene data set through the use of
ensemble feature selection and Network-Cox models [8,
7].
The structure of this article is as follows: Section 2
will describe the data set used for this research. In Sec-
tion 3, introduction will be given to WGCNA. Later in
that section, specific processes regarding co-expression
networks and their construction will be discussed and
explained. Next, survival analysis and Cox models will
be discussed in Section 4. Also in Section 4, couple of
enhancements of Cox regression model, namely Network-
Cox model(4.3) and Ensemble Feature Selection through
the use of linear support vector machines and recursive
feature elimination (4.2) are presented to the reader.
Section 5 will explain a regression approach, namely
logistic regression technique, which measures the rela-
tionship between the predictors and the outcome class,
which, in most cases, is binary. After this, Section 6
shows different experimental setups and discusses their
results. Section 7 summarizes the findings and results of
the research. At last, Section 8 goes through some ad-
ditional enhancements and techniques that might help
and are interesting to investigate in the research of car-
diovascular diseases.
2 Data
Patient data that is used for this study is collected by
CTMM and represents mRNA and clinical data of 461
patients. There are 20826 genes in mRNA data set.
These genes are represented with their expression profiles
over all patients. Clinical data is composed of personal
medical history of patients and the entries representing
times till cardiovascular event occurred. Main focus was
on gene data set rather than classical approach of using
personal patient data as predictors of the cardiovascular
event.
3 Weighted Gene Co-Expression
Network
Gene co-expression networks represent the interaction
between the nodes and helps to investigate the function-
ality of genes on system-level. Construction of such a
networks is straightforward: Nodes represent the genes
and nodes are connected if genes are significantly cor-
related. This already presents one challenge of picking
correct threshold that will define the significance of the
connection. One approach proposed by Steve Horvath
and his team was the idea of giving weight to the con-
nection between each pair of genes [2, 3]. They achieved
this by creating a general framework for ”soft” thresh-
olding that gave the weights to pair of genes in weighted
network. Section 3.1 will mention the steps needed for
construction of such networks. Sections 3.2, 3.3, 3.4 and
3.5 will delve into these steps more in detail. Section 6,
Experiments, will show the result of the Weighted Gene
Co-expression Network analysis and Section 7 and 8 will
mention possible future work that can be done on these
results.
Figure 3.1: Flowchart showing the steps in network con-
struction
3.1 Network construction
Weighted gene co-expression networks are reverse engi-
neering methods for finding the connection and correla-
tion between the genes using genes‘ expression profiles.
Each co-expression network corresponds to an adjacency
matrix, which in its own term encodes the correlation be-
tween each pair of genes. Their construction is essential
in detection of modules and analysis of interconnectivity
among the genes represented in patient data. General
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flowchart for constructing a gene co-expression network
is represented in Figure 3.1.
As it is pointed out in Figure 3.1, first couple of steps
relate to deciding on the measure and the function that
will be used to assign weight of correlation between each
pair of genes in the network. Once the similarity measure
and adjacency function is decided upon, next step is to
find the best fitting parameters.
3.2 Adjacency function and Similarity
measure
First step in gene co-expression network construction is
the decision that has to be made on adjacency func-
tion and similarity measure. This similarity measures
the level of correlation/agreement between gene expres-
sion profiles across all the patients. It is standard to use
Pearson correlation as a similarity/co-expression mea-
sure between pair of genes in network analysis. Pear-
son correlation between genes i and j will be denoted as
sij =| cor(i, j) |. Then, similarity matrix is denoted by
S = [sij ], for all i and j.
Next step is to define adjacency matrix using simi-
larity measure defined above. One way of choosing ad-
jacency matrix that will be using ”soft” thresholding in-
stead of ”hard” thresholding is power adjacency func-
tion. The power adjacency function, aij , is defined as
follows:
aij =| sij |β (3.1)
One important thing to take a look at is that the
power adjacency function uses β in order to determine
the adjacency value between genes i and j. The choice
of β, which is explained in next subsection, is made such
that network fits the scale-free topology.
3.3 Selection of soft-thresholding power
It has been shown that in many real networks, as well
as random networks, the probability that a node is
connected with k other nodes decays as a power law
p(k) ∼ k−γ and this statement is the defining property
of scale-free networks and topology [11]. It is known that
scale-free networks are very heterogeneous and are dom-
inated by a few hub genes that have high connectivity
value.
As already mentioned, one has to select the soft-
threshold power, β, that is used for the computation
of the adjacency function. One way to make a decision
on the value of the β is to look at different values of it
and consider only the ones that lead to a network sat-
isfying scale-free topology. How well the data fits the
model is determined by the coefficient of determination,
R2. High R2 value is an indicator of approximate fit-
ting. Figure 3.2 shows the relation between candidate
values for β and R2 values. It can be seen that, lowest
power for which scale-free topology criterion is satisfied
is 7 (Roughly, R2 ≥ 0.9). β value of 7 is chosen as a
soft-thresholding power for adjacency function for this
data set and is the power used throughout the rest of
this article.
Figure 3.2: Soft-thresholding power selection
One other way of showing that β value of approxi-
mately satisfies scale-free topology is to plot log1 0(p(k))
versus log1 0(k). Higher R
2 value and straighter line is
indicative of the scale-free topology. As it can be seen
from Figure 3.3, our data set actually satisfies scale-free
topology when β value is set at 8.
Figure 3.3: Scale-free topology fit plot
3.4 Module Detection
Important point of co-expression networks is to find set
of genes that are tightly connected to each other. Mod-
ules represent this kind of set of genes. In weighted
gene co-expression networks gene dissimilarity measure
in conjunction with a clustering method identifies mod-
ules. Topological Overlap Mapping based dissimilarity
measure is used for module detection in this article as it
was found to result in biologically meaningful modules
[12]. The topological overlap of two genes reflects their
relative interconnectedness.
In order to define Topological Overlap Mapping
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(TOM), first connectivity of a gene in a weighted net-
work should be defined. Following is the connectivity
measure, ki, of a gene:
ki = Σ
n
j=1aij (3.2)
Ravasz and colleagues proposed the following topo-
logical overlap matrix for unweighted gene co-expression
networks, which is then adapted for weighted co-
expression networks by Steve Horvath and his team:
ωij =
lij + aij
min (ki, kj) + l − aij (3.3)
where lij = Σuaiuauj , and ki is the gene connec-
tivity defined by (3.2). The topological overlap matrix
Ω = [ωij ] is a similarity measure as its entries defined by
(3.3), are non-negative and symmetric. Module detec-
tion in weighted gene co-expression networks makes use
of dissimilarity measure and in order to get TOM-based
dissimilarity measure, TOM-based similarity measure is
subtracted from 1. In other words, the topological over-
lap based dissimalirty measure is defined by the following
formula:
dωij = 1− ωij (3.4)
In order to group genes together into the modules,
one general approach which is also used in this article, is
the usage of hierarchical clustering coupled with TOM-
based dissimilarity dωij .
4 Survival Analysis
In most research projects, one interesting aspect to anal-
yse is the correlation between some covariates/predictors
and an event of interest. Survival analysis is the disci-
pline that aims at creating models that is able to in-
spect the connection between predictors and time-to-
event. This type of analysis is mostly applied in health
sciences from which the name ”survival analysis” is de-
rived, as in most cases event of interest is the time till
death. In case of cardiovascular pathology and research,
event of interest is time till the cardiovascular event hap-
pens. Some examples of cardiovascular events are heart
attacks, infarction and cardiac arrest.
A couple of notations should be made clear about
survival analysis before proceeding forward. One com-
ponent that is of interest in survival analysis, as al-
ready mentioned, is the distribution of survival times.
Commonly used representation of distribution of survival
times is the hazard function, which assesses the instan-
taneous risk of demise at given time t, conditional on
survival time:
h(t) = lim
∆t←0
Pr[(t ≤ T < t+ ∆t)|T ≥ t]
∆t
=
f(t)
S(t)
(4.1)
where T represents survival time, f(t) is the prob-
ability density function and S(t) is the complement of
the distribution function. One example of this, is when
one has a constant hazard, h(t) = v, then this im-
plies an exponential distribution with density function
f(t) = ve−vt.
Common aspect of data sets analysed using survival
analysis is called censoring. The most common format
of censoring represents observations for which trial pe-
riod might have expired or patient might have left the
trial before the event of interest happening, which is
also called right-censoring. In more general terms, cen-
sored data is continuous and means it is unknown if the
event of interest happened or not. Censoring complicates
the likelihood function and modelling process. Cen-
sored data might be either right-censored, left-censored
or both. An observation is Left-censored if its initial
time is unknown. If an observation is both left and right-
censored, then it is called interval-censoring.
Main focus of this article is to analyse how good
of predictors of time till event are some set of genes.
One application of survival analysis that will be focused
on is Cox Proportional-Hazards model. Different ap-
proaches of choosing set of predictor genes exists. Later
in the section, enhancement of simple Cox model, namely
Network-based Cox model proposed by Zhang [7], and
one approach of choosing set of predictor genes, namely
Ensemble Feature Selection, are explained.
4.1 Cox Proportional-Hazards Model
As already mentioned, examination of interest is the re-
lation between predictors and time-to-event. Most com-
monly, this examination entails a linear-like model for
the log-hazard. One way of writing a parametric model
based on the exponential distribution is as following:
log hi(t) = α+ β1xi1 + β2xi2 + . . .+ βkxik (4.2)
or, equivalently,
hi(t) = exp(α+ β1xi1 + β2xi2 + . . .+ βkxik) (4.3)
(4.2) and (4.3) show this relation as linear for log
hazard and multiplicative for the hazard itself. In these
equations, i represents the observation and x′s are the
covariates/predictors. In this article, i represents pa-
tients and x′s are the predictor genes used for creation
of the model. The constant α represents log-baseline
hazard, since log hi(t) = α when all the covariates equal
to zero.
Cox Model is different from generic case as it does
not specify function for baseline hazard α(t) = h0(t).
So, Cox model can be expressed using following formula
which looks similar to equation of parametric model on
the exponential distribution ((4.2)):
log hi(t) = α(t) + β1xi1 + β2xi2 + . . .+ βkxik (4.4)
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or, equivalently,
hi(t) = h0(t) exp(β1xi1 + β2xi2 + . . .+ βkxik) (4.5)
Cox models are semi-parametric, as baseline hazard
α might enter the model in any form, whereas covariates
enter the model linearly. Additionally, Cox models are
proportional-hazards model. One way of showing this
property is to analyse two different observations, namely
i and j, that have different values for their covariates. Let
ηi and ηj represent linear predictors for each observation
accordingly. In other words,
ηi = β1xi1 + β2xi2 + . . .+ βkxik, (4.6)
and, equivalently,
ηj = β1xj1 + β2xj2 + . . .+ βkxjk (4.7)
Then, following two equations are representation of their
hazard models:
hi(t) = h0(t)e
ηi (4.8)
hj(t) = h0(t)e
ηj (4.9)
Using (4.8) and (4.9), the hazard ratio of two obser-
vations can be find:
hi(t)
hj(t)
=
h0(t)e
ηi
h0(t)eηj
=
eηi
eηj
(4.10)
From (4.10), it can be seen that hazard ratio between
two different observations, is independent of time t,
which implies that Cox models are actually proportional-
hazards model.
Cox models offer a couple of advantages. Main ad-
vantage of Cox models is that, baseline hazard should not
be specified, which helps to deal with having arbitrary
and possibly incorrect assumptions about the form of
baseline hazard. As Cox explains in his paper about Cox
proportional-hazards model [13], baseline hazard can be
estimated using the method of partial likelihood.
Although, Cox model is a popular choice for survival
analysis, it has its own disadvantages. One disadvantage
of Cox models is their lack of being able to deal with
high dimensionality of input data. It leads and is linked
with the problem more commonly known as overfitting.
Two different approaches of dealing with this problem
are introduced in next subsections.
4.2 Feature Selection
As already mentioned, Cox models have trouble dealing
with input data that has high dimensionality and high
number of attributes compared to number of samples.
One approach adapted from Abeel et al. [14], is to pre-
process list of genes by using different feature selection
methods in order to reduce the dimensionality of data
set. This approach leads to smaller set of genes selected
as being predictors and representatives of whole gene
set. Feature selection approach is a common technique
used in Machine Learning applications but has drawn
attention in field of Bio-Informatics only lately.
Selection of set of genes out of huge number of genes
for purposes of regression analysis can be looked at as be-
ing an attribute selection problem for classification tasks.
Main aim of attribute selection is to find a small set of
features (genes) that best explains the given data set.
In order to apply feature selection, one of the first
points to take into account is the characteristics needed
from feature selection method. In case of analysis of
large number of genes compared to samples/patients, it
is important that technique to be used scales well to
high-dimensional spaces and it is preferable if the space
complexity of the parameters to be estimated by the se-
lection method depends on the number of the observa-
tions rather than the number of the features. Also, an-
other aspect of an interest is to be able to easily interpret
the results of selection or classification. Linear Support
Vector Machines(SVM) and Recursive Feature Elimina-
tion (RFE) are an interesting choice to exploit, as they
contain all the characteristics and the qualities needed
from the selection method for purposes of this research.
Support Vector Machines
As already mentioned, a linear SVM is a classification
model for which the influence of each gene is explicitly
available and number of features to estimate depends
mainly on the number of patients, rather than on the
number of genes, which is an important feature because
of the small patient-to-gene ratio (approximately, 1:40).
Furthermore, SVMs are known to scale well to high-
dimensional spaces, their performance grow by having
more samples to train on and SVMs have shown state-of-
the-art performance in computational biology problems
[15].
For classification purposes, support vector machines
aim at finding a hyperplane that separates the input
space with maximum margin. Figure 4.1, show an exam-
ple of SVM models. In figure 4.1, H1 does not separate
classes, H2 does separate classes but SVM model that
will be trained in this case is the model corresponding to
the H3 as, it both separates the classes completely and
does that by achieving the maximum margin between
the classes.
Recursive Feature Elimination
Weights of the dimensions (in the case of this research,
genes) show the contribution of that specific dimension
to the hyperplane produced by SVM. These weights can
be used in order to rank the features from most impor-
tant to least important. Recursive feature elimination
exploits this ranking and adopts backward elimination
(p.5)
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strategy in order to iteratively eliminate least important
genes. Starting from full set of genes, a linear SVM is es-
timated and least important genes are eliminated. Dur-
ing next iteration, a linear SVM is estimated using only
remaining set of features and again fraction of genes is
removed from set of all genes. This procedure continues
until desired number of genes is reached or there are no
more genes to eliminate.
Figure 4.1: Simple example of an SVM model in two-
dimensional space
One important parameter for RFE is the fraction of
the genes, E, to be eliminated every iteration of feature
elimination method. This parameter plays essential role
in time complexity of the feature elimination. Reducing
the value of E increases time complexity of the algorithm.
In order to rank all the features at once, E should be set
at 100%. For purposes of this research, E is set at 20%,
meaning
1
5
th
of the remaining genes is eliminated at the
end of each iteration. Genes are ranked by the absolute
value of their weight during the iteration they have been
eliminated. Genes removed at later iterations are put on
top of the ranking.
Sensitivity analysis of fraction E has been analysed
in biomarker detection paper by Abeel [14] and it has
been shown that choice of this parameter does not affect
overall stability of feature selection. Thus, sensitivity
analysis is disregarded in this article.
Ensemble Feature Selection and Bootstrapping
SVM and RFE are feature selection techniques that can
provide good results most of the times. In order to in-
crease the stability of feature selection, power of these
two methods are combined into ensemble feature selec-
tion technique. Ensemble feature selection makes use
of both SVM and RFE in order to give ranking to set
of features separately and returns aggregated result of
these two methods.
Another enhancements added to feature selection is
the bootstrapping of samples. Bootstrapping is the com-
mon approach used in Machine Learning for reduction of
variance. It creates diverse training sets (with replace-
ment) by including part of the original data set in order
to train SVM and RFE models on. Bootstrapping used
in this research is simple random sample with replace-
ment, meaning there is a chance for an individual to
appear more than once in the subset.
More formally, following notation can be made about
feature selectors and results obtained from those: Let
FSi represent i
th feature selector. Assumption can be
made on that, each FSi will return set of ranking val-
ues for each gene, which in its turn can be noted more
formally as fsri,k = (f
1
i,k, ..., f
N
i,k, where f
j
i,k denotes the
rank of feature j at the bootstrap k using feature selector
i and N denotes the number of features. In case of this
research, aggregation is done on results obtained from
RFE, which internally uses SVM. Different RFE classi-
fiers have been applied on different bootstrap samples
and once the results are obtained, they are aggregated.
For aggregating the results obtained by bootstrap-
ping the training data, one scheme proposed is the Com-
plete linear aggregation. Complete linear aggregation
gives equal weight to different bootstrap samples and
sums up the rankings of a given feature over all boot-
strapped samples in order to get final result. Aggregated
rank of all the features obtained from selector FSi using
complete linear aggregation can be computed as follows:
fi = (Σ
t
k=1fsr
1
i,k, ...,Σ
t
k=1fsr
N
i,k), (4.11)
where t represents the number of bootstrap samples used
for ensemble feature selection.
4.3 Network-Cox model
As already mentioned, Cox regression performs and gen-
eralizes poorly when the dimensionality of input data is
high. Most common techniques used in prior is the in-
troduction of so-called L1 and L2 - norm penalties to
Cox regression models. One novel approach proposed by
Wei Zhang [7] is the combination gene co-expression net-
works and cox models. Network-Cox models exploits the
information about modular relations among genes which
has been mostly ignored in previous survival analysis re-
search and the fact that groups of genes are co-expressed
under certain conditions.
Gene co-expression network used in Network-Cox
model is similar to the one computed in Section 3. It uses
(p.6)
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Pearson correlation coefficients for computing the corre-
lation level among genes using gene expression dataset.
In order to include network information into Cox re-
gression models, following constraint is added to general
formulation of Cox model mentioned in (4.3):
lpen(β, h0) = l(β, h0)− 1
2
λβ′[(1− α)L+ αI]β, (4.12)
where λβ′[(1−α)L+αI]β represents the Laplacian con-
straint which is a encoding of a prior knowledge obtained
from network. L in (4.12), is a positive semidefinite ma-
trix derived from network information, I is an identity
matrix, λ is a parameter controlling the weighting be-
tween total likelihood and the network constraint. α
is another parameter controlling the weighting between
network matrix and identity matrix in network con-
straint. Decision on the values of these variables are
subject to Section 5.
The objective function defined by (4.12), can be
solved by alternating the optimization of β and baseline-
hazard function h0(t). For optimization of β, Newton-
Raphson method is used. Before, explaining the
Newton-Raphson method for optimization, first and sec-
ond derivatives of the objective function with respect to
β should be defined. The first derivative of the objective
function is as follows:
δlpen(β, h0)
δβ
= X ′∆− λΓβ, (4.13)
where ∆ = δ − exp(X ′β)H0(t)
The second derivative of the objective function is de-
fined as follows:
δ2lpen(β, h0)
δβδβ
= −X ′DX − λΓ, (4.14)
where D is the diagonal matrix with Dii =
exp(X ′iβ)H0(ti). Now, given this information, Network-
Cox model can be solved using following algorithm pro-
posed by Zhang [7].
As it can be seen, from third phase of Newton-
Raphson iteration, in order to optimize β, inverse of
second order partial derivatives, also called the Hessian
matrix, of the objective function should be computed,
which is a time consuming operation. An alternative to
this approach is to reduce the covariant space from p to
n, where p represents amount of genes and n represents
amount of patients. This approach relates the singular
value decomposition which in its turn exploits the low
rank of the gene expression matrix X. Using simple cal-
culus, one can see that from
δlpen(β, h0)
δβ
= X ′∆− λΓβ = 0, (4.15)
Data: X - gene expression profiles, S -
normalized graph weight matrix
Result: Returns β, weights of each feature/gene
1. Initialization : β = 0; Compute L = I − S
2. Do until convergence
(a) Do Newton-Raphson iteration
i. Compute the first derivative
δlpen(β, h0)
δβ
ii. Compute the second derivative
δ2lpen(β, h0)
δβδβ
iii.Update β = β − l′′pen(β, h0)
−1
l
′
pen(β, h0)
(b) Update h0(ti) = 1/Σj∈R(ti)exp(X
′
jβ)
3. Return β
Algorithm 1: Solution algorithm for Net-Cox models
it can be implied that β = Γ−1X ′η for some value
of η. So, using this information, objective function of
Network-Cox model can be written as:
lpen(η, h0) = Σ
n
i=1(−exp(Z ′iη)H0(ti)+δi[log(h0(ti))+Z ′iη])
− 1
2
λη′Zη. (4.16)
In (4.16), Z = XΓ−1X ′. This equation is the dual
form of the(4.12), and it is obvious that those two equa-
tions are equal but the problem dimension is reduced
from p to n. So, using the Algorithm 1 and (4.15) and
(4.16), it is possible to optimize β and solve the Network-
Cox model. Figure 4.2, shows the overall flow, struc-
ture and the construction of the Network-Cox model ex-
plained earlier in the subsection.
Figure 4.2: Overview and the overall flow of Network-
Cox model, taken from [7]
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5 Regression
Survival analysis mainly deals with the prediction of an
event happening or not and if it does, time it takes for
an event to happen given some covariates. In the car-
diovascular research, it is equally interesting to look into
other variables/symptoms that might be a cause of a
disease or an event. Some examples of these symptoms
are diabetes, blood pressure and dyslipidemia. As these
variables are not survival data, different approach should
be used for exploring the effects of different genes or gene
sets. One method that is used in this paper is logistic
regression as most of the clinical patient history data is
binary and logistic regression is the common technique
used for evaluating the effects and significance of genes
as the predictors of the outcome class. Next subsection
explains logistic regression in more detail.
5.1 Logistic regression
Logistic regression is a statistical model that fits the non-
linear model representing the relation between predictor
and discrete variable. Discrete variable in case of this
research, is the outcome class of interest(diabetes, dys-
lipidemia etc.) and predictors are genes and their ex-
pression profiles over all patients. In logistic regression
analysis, outcome class is binary(true/false, 1/0, yes/no
etc.) and main purpose of analysis is to assess the ef-
fect of multiple explanatory variables on the outcome
class. As values of diabetes and dyslipidemia are logistic
(yes/no), it is only fitting to exploit logistic regression.
As name already suggests, logistic regression uses a
logistic function for prediction step. The logistic func-
tion is defined as follows:
F (t) =
et
et + 1
, (5.1)
where t can be viewed as being a linear function of an
predictor x. Then, logistic function can be written as:
F (x) =
1
1 + e−(β0+β1x)
(5.2)
(5.2) determines the probability assigned by logistic
regression for a probability of having a success or not.
Figure 5.1, shows the plot of simple logistic function.
Logistic function is extra useful because it can take any
value between negative infinity and positive infinity as
its input, and return the value between 0 and 1, which in
its turn is interpretable as a probability. F (x) illustrates
that the probability of outcome class being equal to a
case is equal to the value of the logistic function of the
linear regression expression.
Figure 5.1: Simple plot of a logistic function
Equations shown above represent the logistic func-
tion for logistic regression where there is only one pre-
dictor. It is possible to adopt those equations for a
case of multiple explanatory variables. In case of mul-
tiple explanatory variables, β0 + β1x is replaced by
β0+β1x1+...+βixi. Here, β0 is the value of the criterion
when the predictor values are all zero and β1, ...βi repre-
sents the contribution weights of each feature/predictor
to the whole model. In general, for linear regression, β
values are found using maximum likelihood estimation.
In case of logistic regression, it is not possible to find
a closed-form expression that maximized the likelihood
value. Because of this, iterative methods for numerical
approximations are used. Most common techniques used
for numerical estimations is Newton‘s method which is
explained elsewhere [16].
Logistic regression is combined with feature selection
explained in Section 4, in order to fight the same kind of
overfitting problem explained in Cox models. Predictor
genes that are examined using logistic regression is the
set of genes ranked highest by Feature selection meth-
ods. Section 6 will delve into different uses of logistic
regression.
6 Experiments
For purposes of experimentation, R programming lan-
guage combined with Bio-conductor and WGCNA [3]
package were used for Module Detection and network
construction.
Next, main focus of experiments was shifted from cor-
relation among genes to correlation between genes and
clinical data of patients. Java-ml [17] Ensemble Fea-
ture selection tool combined with Matlab implementa-
tion of Network-Cox regression were used as tools for
finding possible target genes predicting the medical pa-
tient data. Examples of medical data include diabetes
(p.8)
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and dyslipidemia. These variables were chosen for the
analysis, as they are known to affect the overall process
of the atherosclerosis.
Results of each of these experiments is discussed in
next subsections.
6.1 Module detection
For purposes of module detection, WGCNA package
available for R programming language has been used.
After the discussion with specialists in the field, it was
agreed to set minimal allowable size of the module to be
at 80. Figure 5.1, shows the dendrogram of the mod-
ule detection. As it can be seen from Figure 5.1, there
were 13 modules detected by WGCNA. Grey module
represents the genes that were not included in any of the
modules.
These modules represent possible biological connec-
tions among genes, as already mentioned in Section 3. To
get better understanding of these results, further analy-
sis can be applied on modules separately, which is out of
scope of this paper.
Figure 6.1: Dendrogram of the modules obtained from
WGCNA
6.2 Feature Selection
First experiment was performed in order to rank the fea-
tures considering their contribution and weight at pre-
diction of different clinical data. One variable of interest
in feature selection experiments was diabetes. Diabetes
feature is a binary one, where 1 represents patient hav-
ing diabetes and 0 otherwise. As mentioned in Section 4,
Ranking Gene ID Already related dis-
eases/disorders
1. UTS2 Atherosclerosis and car-
diovascular diseases
2. PRKAR1A Hypocalcemia
3. IPO8 Alcoholism
4. HIST1H4C Cancer and non-hodgkin
lymphoma
5. GRHPR Renal failure
6. HLA-C Psoriasis and Leukemia
7. CLEC4F Unknown
8. KIAA0226L Cervical intraepithelial
neoplasia and esophagitis
9. NQO2 Agranulocytosis
10. TIMM22 Unknown
Table 1: Top 10 contributing genes to the RFE model of
diabetes
Ensemble feature selection technique was applied on the
data set. For this experiment, 10 bootstrapped data sets
were used to train RFE model on them and the results
of these 10 feature selectors were aggregated. Table 1
shows top 10 genes (Associated diseases have been re-
trieved from gene card website):
From Table 1, it can be seen that, top ranked gene
UTS2 has already been associated with cardiovascular
diseases and atherosclerosis. Additionally, most of the
genes in top 10 have been shown to have relevance with
atherosclerosis. For example, PRKAR1A has been asso-
ciated with Hypocalcemia, which in its turn has chronic
renal failure as its cause. Renal failures are known to
be of importance for diagnosis of atherosclerosis and is
a factor taken into account by physicians and doctors.
Furthermore, GRHPR gene directly relates to renal fail-
ure. KIAA0226L is associated with esophagitis which
is shown to lead to higher tendency for atherosclerosis,
diabetes and heart failure [18].
On top of the facts mentioned, there are also two
genes in top 10, namely CLEC4F and TIMM22, that
are not known to be associated with any disease, making
their possible future analysis more interesting.
Next to the diabetes, ensemble feature selection with
the same parameters as mentioned above was applied
to find the most important genes contributing to the
prediction of dyslipidemia. Top 10 genes are presented
on Table 2.
From Table 2, it can be seen that, as in the case of
diabetes, some of the genes assessed as being more con-
tributing by Ensemble Feature Selection have already
been associated with atherosclerosis. Also, there were
genes in the top 50, that were associated with atheroscle-
rosis but those genes are not included in Table 2, as they
were not part of the top 10. One example of such a gene
(p.9)
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Ranking Gene ID Associated dis-
ease/disorder
1. SNAP29 Schizophrenia
2. CLEC4D Immunodeficiency
3. DNAJC15 Ovarian cancer and Ade-
nocarcinoma
4. GSTT1 Cancer and Asbestosis
5. CHST7 Thyroiditis
6. TNF Inflammation and tumors
7. TNNT1 Myocardial infarction and
type 1 Diabetes
8. CMPK2 Multiple sclerosis
9. LRRN3 Neuroblastoma
10. IKZF1 Non-hodgkin lymphoma
and Lupus Erythematosus
Table 2: Top 10 contributing genes to the RFE model of
dyslipidemia
is SELL.
Above mentioned results show that feature selection
on its own can determine important genes in the study
of cardiovascular diseases. Next to the ability of finding
target genes already associated with disease, it also offers
possible new target genes that should be further anal-
ysed. These conclusions suggest that it is an interesting
alternative to include the feature selection techniques in
future research.
6.3 Network-Cox Regression
One of the main parameters analysed in cardiovascular,
as well as cancer, research is the survival data of the pa-
tients. This data represents the time it took for an event
to happen, if that event happens. Details about survival
data has been explained in earlier sections. Network-
Cox model has been applied on the data set in order to
assess the significance and importance of the genes on
the prediction process.
In this particular case, it was unsuccessful to per-
form Network-Cox regression, as the 2nd step of the al-
gorithm, in which Newton-Raphson method is used for
optimization of the weights, did not converge, making
computations less meaningful. That was the reason why,
Network-Cox regression results were discarded from this
paper. Possible solutions to this problem are presented
in Section 8.
6.4 Logistic Regression
Next step on analysis of the genes that show high rank-
ings during feature selection step, is the assessment of
their statistical significance at the prediction of the di-
abetes and dyslipidemia. For this experiment, top 50
genes were assessed as being predictors of the diabetes
and dyslipidemia.
Gene ID p-value Ranking
UTS2 0.016807 1
SYT10 9.28e-05 39
IPO8 0.042734 3
HIST1H4C 0.014305 4
ID1 0.000123 32
NQO2 0.005885 9
MMP9 0.000490 25
FPR1 0.000875 14
ENC1 0.005429 17
CLEC4F 0.045308 7
Table 3: P-Values of more significant genes from top 50
selected by EFS for diabetes model
Main purpose of regression analysis was to further
identify more important genes or get the results already
obtained by other scholars in their research.
First variable of interest as already mentioned was
the diabetes among the patients. Top 50 genes obtained
from ensemble feature selection were used for this ex-
periment. As table gets very big, only more interesting
genes, their p-values and their rankings obtained from
ensemble feature selection are shown below:
As it can be seen from Table 4, all of the above
mentioned genes are significant for the prediction of the
diabetes. Among them, NQO2,UTS2,HIST1H4C were
among the top 10 genes and their relevance to overall
atherosclerosis has already been mentioned in Feature
selection experiments. SYT10 is one gene that should
be taken into account as it has very low p-value, meaning
higher significance of this gene and also added fact of it
being in top 50 genes chosen by feature selection tech-
nique and not being associated with any kind of disease
or disorder, makes SYT10 gene an interesting target for
future research. Furthermore, CLEC4F has not been as-
sociated with any diseases so far, but it both appeared
in most chosen 10 genes and it shows good enough level
of contribution to logistic model, as its p-value is smaller
than 0.05, which is a value adopted and used by almost
every research group and scholar for assessment of sig-
nificance. One more interesting gene in above table is
MMP9, because it has been associated with atheroscle-
rosis, inflammation and cardiovascular diseases. ID1 has
been associated with neovascularization which is related
to atherosclerosis. These facts further prove that, feature
selection and logistic regression are interesting alterna-
tives and their results, especially the genes that have not
been associated with atherosclerosis, should further be
analysed.
Next experiment was the evaluation of significance
of top 50 genes for the case where prediction class (in-
dependent variable) is dyslipidemia. As in case of dia-
(p.10)
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Gene ID p-value Ranking
WWC2-AS2 6.94e−6 18
SNAP29 0.00570 1
GSTT1 0.00643 4
TNNT1 0.00635 7
CLEC4D 0.00536 2
TNF 0.01783 6
PRDX2 0.00158 39
Table 4: P-Values of the more significant genes out of
top 50 chosen by EFS for dyslipidemia model
betes, this variable is binary (0 - no, 1 - yes). Following
table shows the genes with lowest p-values, their gene
IDs and their rankings obtained from feature selection
experiment.
Diseases associated with some of the genes shown
in Table 4, have already been explained in Table 2.
There are also additional genes, namely WWC2-AS2
and PRDX2, who show quite a low p-value statistic in
logistic regression experiment. Checking their gene card,
it can be seen that, WWC-AS2 has not been associated
with any disease and PRDX2 has been associated with
vasculitis (inflammation of the blood vessels), endothe-
liitis(immune response within the endothelium in blood
vessels, in which they become inflamed. Has been asso-
ciated with atherosclerosis) and shock.
Above mentioned results, prove that Ensemble Fea-
ture selection by itself and when combined with logis-
tic regression, can produce interesting and correct set of
genes. Correct set of genes, in this case, represent the
genes that have already been linked to atherosclerosis.
These characteristics makes them a possible prospective
technique to use in cardiovascular research.
7 Conclusion
As a conclusion, Weighted gene co-expression networks
are still an interesting approach that is used by many
others. Modules detected by WGCNA package could
have been further analysed for enriched pathways, on-
tologies or transcription factors, but this kind of analysis
was out of scope of this paper.
Feature selection techniques combined with regres-
sion models seemed to be an interesting alternative, as
their results present the genes already related to car-
diovascular diseases. Next to these genes, results also
suggest to further analyse some genes, namely SYT10
and CLEC4F. These methods have not been used exten-
sively by other scholars, making them more appealing to
exploit.
Unfortunately, Network-Cox models did not succeed
at experiments. As already mentioned in Section 6,
Newton-Raphson step of the algorithm was not con-
verging under the given iteration limits, leading to the
weights that are not optimised. This problem was the
reason why the results obtained from Network-Cox mod-
els were not included in the paper and were discarded.
Even though, Network-Cox failed to produce more mean-
ingful results in this research, the technique still remains
as an interesting alternative in future research. Possible
ways of tackling the problem of not convergence are ex-
plained in next section and those might lead to the more
desired results.
8 Future Work
As already mentioned, one possible further analysis for
better understanding of the biological processes happen-
ing among genes, Gene Ontology Enrichment Analysis,
Transcription Factor analysis and MicroRNA analysis
could have been performed on the modules detected by
WGCNA modules. Furthermore, intramodular connec-
tivity analysis can be included for finding central hub
genes of each module, which has been shown to be of
interest for research [10].
Additionally, Feature Selection experiments could be
further extended to include different techniques in order
to improve results and possibly find more target genes
for future research. One experiment not performed as a
part of this paper is the combination of Feature selection
and simple Cox model, which might be an interesting ap-
proach for subsequent research. Also, Ensemble Feature
Selection, Logistic Regression and Network-Cox models
explained in this paper can be used to examine the re-
lation between genes and different variables that are of
interest for cardiovascular research that were not exam-
ined in this paper. Multi-class regression might have
been added for the assessment of the link between the
genes and multiple variables of interest at the same time.
Another problem faced during the Network-Cox
model experimentations was the not convergence of
the Newton-Raphson method under the given iterations
limit of 1000. This problem could be tackled by either
increasing number of iterations or using different numer-
ical method for the optimization of the weights of the
model.
Once results are obtained from above mentioned
techniques, more in-detail analysis of candidates for be-
ing a target gene should be performed in order to prove
their relevance to the atherosclerosis and its symptoms.
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